590 results on '"Ip, James E"'
Search Results
2. Podcast on Self-administered Intranasal Etripamil for Symptomatic Paroxysmal Supraventricular Tachycardia: The RAPID Trial
3. Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings
4. Ventricular Tachycardia Due to Triggered Activity: Role of Early and Delayed Afterdepolarizations
5. Localized Re-Entry Is a Frequent Mechanism of De Novo Atypical Flutter
6. Six-month electrical performance of the first dual-chamber leadless pacemaker
7. Constitutively Activating GNAS Somatic Mutation in Right Ventricular Outflow Tract Tachycardia.
8. Multicenter, Phase 2, Randomized Controlled Study of the Efficacy and Safety of Etripamil Nasal Spray for the Acute Reduction of Rapid Ventricular Rate in Patients With Symptomatic Atrial Fibrillation (ReVeRA-201)
9. Dual-chamber leadless pacing: Atrioventricular synchrony in preclinical models of normal or blocked atrioventricular conduction
10. Abstract 12390: Differences in the Impact of Use of Contact Force Sensing Catheters on Subsequent Rates of Pulmonary Vein Reconnection Detected Between Men and Women During Repeat Ablation of Atrial Fibrillation
11. Retrieval of Chronically Implanted Dual-chamber Leadless Pacemakers in an Ovine Model
12. Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial
13. Population-Level Prevalence of Rare Variants Associated With Atrial Fibrillation and its Impact on Patient Outcomes
14. Safety and Efficacy of a Novel Approach to Pulmonary Vein Isolation Using Prolonged Apneic Oxygenation
15. Etripamil Nasal Spray for Recurrent Paroxysmal Supraventricular Tachycardia Conversion
16. Rates of pulmonary vein reconnection at repeat ablation for recurrent atrial fibrillation and its impact on outcomes among females and males
17. Postmortem examination of a dual-chamber leadless pacemaker system: Implications for chronic atrial leadless pacemaker removal
18. Outcomes of patients with heart failure with preserved ejection fraction undergoing catheter ablation of atrial fibrillation
19. Early Stroke and Mortality After Percutaneous Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation
20. Predictors of Shock-Reduction Programming and Its Impact on Implantable Cardioverter-Defibrillator Therapies and Mortality: The CERTITUDE Registry.
21. Pharmacokinetics and Pharmacodynamics of Etripamil, an Intranasally Administered, Fast‐Acting, Nondihydropyridine Calcium Channel Blocker
22. Reappraisal of electrocardiographic criteria for localization of idiopathic outflow region ventricular arrhythmias
23. Double-snare technique for helix-fixation leadless cardiac pacemaker retrieval
24. First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301)
25. Abstract 9925: Patient-Reported Treatment Satisfaction in Etripamil-Mediated Conversion of Supraventricular Tachycardia to Sinus Rhythm: Results From the NODE-301 Study
26. The Left Atrial Appendage Ostium: Hotspots for Localized Re-Entry
27. Trends and Outcomes of Catheter Ablation of Ventricular Tachycardia in Patients With Ischemic and Nonischemic Cardiomyopathy
28. Ventricular Tachycardia Due to Triggered Activity
29. A Multicenter, Phase 2, Randomized, Controlled Study of the Efficacy and Safety of Etripamil Nasal Spray for the Acute Reduction of Rapid Ventricular Rate in Patients with Symptomatic Atrial Fibrillation (ReVeRA-201)
30. Conventional and Novel Methods for Early Retrieval a Helix-Fixation Leadless Cardiac Pacemaker
31. Essential Role of Endothelial Sphingolipid Biosynthesis in Cerebrovascular Homeostasis
32. Risk of Mortality Following Catheter Ablation of Atrial Fibrillation
33. Insertable cardiac monitor extraction technique: hook and reel
34. Etripamil Nasal Spray for Conversion of Repeated Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia During Long‐Term Follow‐Up: Results From the NODE‐302 Study
35. Leadless Pacemaker Implantation Using a Superior Approach When a Conventional, Femoral Implant Fails
36. Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial
37. Arrhythmic Complications of Patients Hospitalized with COVID-19: Incidence, Risk Factors and Outcomes
38. Idiopathic malignant premature ventricular contractions
39. Left atrial thrombus despite continuous direct oral anticoagulant or warfarin therapy in patients with atrial fibrillation: insights into rates and timing of thrombus resolution
40. Completely wireless: First concomitant dual-chamber leadless pacemaker and subcutaneous defibrillator implant
41. A Dual-Chamber Leadless Pacemaker
42. PO-04-173 CORRELATION BETWEEN ARRHYTHMIC MITRAL VALVE PROLAPSE SUBSTRATE AND VENTRICULAR ARRHYTHMIAS
43. PO-05-010 PERMANENT PACEMAKER IMPLANTATION OUTCOMES FOLLOWING SURGICAL AORTIC VALVE REPLACEMENT: A NATIONAL READMISSIONS DATABASE ANALYSIS
44. PO-02-050 IMPACT OF HOSPITAL LEAD EXTRACTION PROCEDURAL VOLUME ON MANAGEMENT OF PATIENTS WITH CARDIAC IMPLANTABLE ELECTRONIC DEVICES HOSPITALIZED WITH INFECTIVE ENDOCARDITIS
45. CI-452765-4 SEX-BASED DIFFERENCES IN TRANSVENOUS LEAD EXTRACTION MANAGEMENT AND OUTCOMES AMONG PATIENTS WITH CARDIAC IMPLANTABLE ELECTRONIC DEVICES-ASSOCIATED INFECTIVE ENDOCARDITIS
46. Synergistic Effects of Cation Supplementation for Pharmacologic Conversion of Atrial Fibrillation
47. Low Utilization of Lead Extraction Among Patients With Infective Endocarditis and Implanted Cardiac Electronic Devices
48. Advanced helix‐fixation leadless cardiac pacemaker implantation techniques to improve success and reduce complications
49. LB-456640-1 PERCUTANEOUS IMPLANTATION OF A DUAL CHAMBER LEADLESS CARDIAC PACEMAKER SYSTEM WITH BIDIRECTIONAL COMMUNICATION FOR ATRIOVENTRICULAR SYNCHRONY
50. PO-02-069 UTILITY OF EXIT MAPPING FOR CHARACTERIZING SITES OF RESIDUAL PULMONARY VEIN CONDUCTION FOLLOWING FAILED FIRST-PASS PULMONARY VEIN ISOLATION WITH RADIOFREQUENCY ABLATION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.